The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it is offering no-cost feature updates for t:slim X2 ...

Tandem Diabetes has announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is now available with Abbott’s FreeStyle Libre 3 Plus ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update ...

Tandem Diabetes Care ($TNDM), the maker of the t:slim insulin pump, has partnered with open-source software provider Tidepool. The deal is expected to better enable ...

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q3 CY2025 results exceeding the market’s revenue ...

Tandem Diabetes Care launched a new predictive feature designed to help reduce the frequency and duration of low-glucose events by pausing insulin delivery. The technology is available as a free ...

The technology went through the FDA’s new interoperability pathway, which encourages device-makers to build products that can be used across systems or platforms. Both Tandem Diabetes’ software and ...

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings this Thursday after the bell.

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today commenced shipments of t:slim Pumps featuring enhanced software.

The tool will let pump users get updates of new features in between replacement of their hardware. Tandem Diabetes Care has received FDA clearance for a tool designed to allow remote updates for its ...

“Our ability to provide our customers with remote feature updates exemplifies our Company’s mission to improve the lives of people with diabetes through relentless innovation and revolutionary ...